Robert Frick is Editorial Director of Investing Daily. Bob is a career business and financial journalist, with a 15-year tenure as senior editor for Kiplinger’s Personal Finance magazine, in addition to working as a newspaper business writer and editor, and a stint as an investment writer for USA Today.
He’s a nationally recognized authority on behavioral finance, and worked two years as a writer, researcher and speaker for the Allianz Global Investors Center for Behavioral Finance.
He has co-authored three books on personal finance, and holds an M.B.A. and a B.A. (Journalism) from the Pennsylvania State University
Unfortunately, this is the final issue of Pacific Wealth. In investing, timing isn’t everything, but in this case it hastened the demise of this service. Subscribers’ remaining months will be fullfilled by our excellent Global Income Edge letter, which has proven itself a great source for strong income and international… Read More
We are adding Merck & Co. (NYSE: MRK) to the Global Income Edge Conservative Portfolio. In a continuation of our focus on solid health care stocks that we will provide solid dividend income, we found Merck & Co. to be undervalued now after the latest market declines and a management… Read More
We have three changes in the Canadian Edge Dividend Champion’s portfolio:Potash Corp. (POT): Moved from Hold to Buy because share price declined 20% after competitor Mosaic curtailed potash production due to slow North American demand. Buy below C$35 or US$27.Canadian National Railway (CN): Moved from Buy… Read More
Hillenbrand (NYSE: HI) fits the Global Income Edge investment thesis like a glove as a company that is dominant in the U.S. market but offers higher growth opportunities from international markets. The company is the dominant casket and funeral services provider in the U.S, under the 100-year old Batesville brand, and also has… Read More